IL-6 levels decrease with SSRI treatment in patients with major depression

Basterzi A., Aydemir C., Kisa C., Aksaray S., Tuzer V., Yazici K., ...Daha Fazla

HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, cilt.20, sa.7, ss.473-476, 2005 (SCI-Expanded, Scopus) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 20 Sayı: 7
  • Basım Tarihi: 2005
  • Doi Numarası: 10.1002/hup.717
  • Dergi Adı: HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.473-476
  • Anahtar Kelimeler: antidepressants, cytokines, IL-6, major depressive disorder, ACUTE-PHASE PROTEINS, PLASMA-LEVELS, ACUTE STATE, INTERLEUKIN-6, CYTOKINES, BEHAVIOR, RECEPTOR, ALPHA, AXIS
  • Ankara Üniversitesi Adresli: Evet

Özet

Objective Some evidence indicates that an immune response with an increased production of proinflammatory cytokines often accompanies major depression. The objective of this study was to examine the serum levels of IL-6 in patients with major depression and the changes occurring in IL-6 levels during treatment with selective serotonin reuptake inhibitors (SSRI).